The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Open accessAbstract
ANANDAMIDE (N-arachidonoyl-ethanolamine) was recently identified as a brain arachidonate derivative that binds to and activates cannabinoid receptors14, yet the mechanisms underlying formation, release and inactivation of this putative messenger molecule are still unclear. Here we report that anandamide is produced in and released from cultured brain neurons in a calcium ion-dependent manner when the neurons are stimulated with membrane-depolarizing agents. Anandamide formation occurs through phos-phodiesterase-mediated cleavage of a novel phospholipid precursor, N-arachidonoyl-phosphatidylethanolamine. A similar mechanism also governs the formation of a family of anandamide congeners, whose possible roles in neuronal signalling remain unknown. Our results and those of others5,6indicate therefore that multiple biochemical pathways may participate in anandamide formation in brain tissue. The life span of extracellular anandamide is limited by a rapid and selective process of cellular uptake, which is accompanied by hydrolytic degradation to ethanolamine and arachidonate. Our results thus strongly support the proposed role of anandamide as an endogenous neuronal messenger.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 702
Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., & Devane, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7656 · Cited by 475
N-Acylated glycerophospholipids and their derivatives
Schmid, H. H. O., Schmid, P. C., & Natarajan, V. (1990) · Progress in Lipid Research · doi:10.1016/0163-7827(90)90004-5 · Cited by 451
Primary culture of identified neurons from the visual cortex of postnatal rats
Huettner, J., & Baughman, R. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-10-03044.1986 · Cited by 443
Kato, K., Clark, G. D., Bazan, N. G., & Zorumski, C. F. (1994) · Nature · doi:10.1038/367175a0 · Cited by 248
Schmid, P. C., Reddy, P. V., Natarajan, V, & Schmid, H. H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44667-9 · Cited by 232
Devane, W. A., & Axelrod, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6698 · Cited by 220
NGF gene expression in actively growing brain glia
Lu, B., Yokoyama, M., Dreyfus, C., & Black, I. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00318.1991 · Cited by 212
Properties of rat liver N-acylethanolamine amidohydrolase.
Schmid, P. C., Zuzarte-Augustin, M. L., & Schmid, H. H. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38695-7 · Cited by 197
Cited by
Items 101–198 of 198
Huang, S. M., Bisogno, T., Petros, T. J., Chang, S. Y., Zavitsanos, P. A., Zipkin, R. E., Sivakumar, R., Coop, A., Maeda, D. Y., De Petrocellis, L., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107351200 · Cited by 339
Self-citationAnandamide Amidohydrolase Activity in Rat Brain Microsomes
Desarnaud, F., Cadas, H., & Piomelli, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6030 · Cited by 336
Self-citationEgertová, M., Giang, D. K., Cravatt, B. F., & Elphick, M. R. (1998) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1998.0543 · Cited by 334
Mazzari, S., Canella, R., Petrelli, L., Marcolongo, G., & Leon, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00015-5 · Cited by 332
Chemical Probes of Endocannabinoid Metabolism
Blankman, J. L., & Cravatt, B. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006387 · Cited by 327
Identification of intracellular carriers for the endocannabinoid anandamide
Kaczocha, M., Glaser, S. T., & Deutsch, D. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901515106 · Cited by 326
Felder, C. C., Nielsen, A., Briley, E. M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D. N., Richardson, J. M., Riggin, R. M., Koppel, G. A., et al. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00891-5 · Cited by 326
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation
Dinh, T. P., Freund, T. F., & Piomelli, D. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00150-0 · Cited by 320
Self-citationBiosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP
Cadas, H., Gaillet, S., Beltramo, M., Venance, L., & Piomelli, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03934.1996 · Cited by 319
Self-citationEndogenous cannabinoid system as a modulator of food intake
Cota, D., Marsicano, G., Lutz, B., Vicennati, V, Stalla, G. K., Pasquali, R., & Pagotto, U. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802250 · Cited by 315
Di Marzo, V. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00042-3 · Cited by 312
Self-citationBisogno, T., Berrendero, F., Ambrosino, G., Cebeira, M., Ramos, J. A., Fernandez-Ruiz, J. J., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0254 · Cited by 312
Self-citationEndocannabinoids: synthesis and degradation
Di Marzo, V. (2006) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_0505 · Cited by 311
Self-citationEvidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor
Sugiura, T., Kodaka, T., Nakane, S., Miyashita, T., Kondo, S., Suhara, Y., Takayama, H., Waku, K., Seki, C., Baba, N., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2794 · Cited by 310
Ueda, N., Kurahashi, Y., Yamamoto, S., & Tokunaga, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23823 · Cited by 303
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids
Bacci, A., Huguenard, J. R., & Prince, D. A. (2004) · Nature · doi:10.1038/nature02913 · Cited by 306
Multiple pathways involved in the biosynthesis of anandamide
Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H.-Y., Luquet, S., Palmiter, R. D., Krystal, G., Rai, R., Mahadevan, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.020 · Cited by 304
di Marzo, V., Hill, M. P., Bisogno, T., Crossman, A. R., & Brotchie, J. M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1432 · Cited by 303
Self-citationCannabinoid Hyperemesis Syndrome
A. Galli, J., Andari Sawaya, R., & K. Friedenberg, F. (2011) · Current Drug Abuse Reviewse · doi:10.2174/1874473711104040241 · Cited by 303
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
Cravatt, B. F., & Lichtman, A. H. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00079-6 · Cited by 302
Rouzer, C. A., & Marnett, L. J. (2011) · Chemical Reviews · doi:10.1021/cr2002799 · Cited by 302
Yamashita, A., Sugiura, T., & Waku, K. (1997) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021715 · Cited by 300
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
Bouaboula, M., Hilairet, S., Marchand, J., Fajas, L., Fur, G. L., & Casellas, P. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.032 · Cited by 298
Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296
Self-citationInhibition of tumor angiogenesis by cannabinoids
Blázquez, C., Casanova, M. L., Planas, A., Gómez del Pulgar, T., Villanueva, C., Fernández‐Aceñero, M. J., Aragonés, J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0795fje · Cited by 292
van der Stelt, M., & Di Marzo, V. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.101 · Cited by 291
Self-citationBerrendero, F., Sepe, N., Ramos, J. A., Di Marzo, V., & Fern�ndez-Ruiz, J. J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990901)33:3<181::aid-syn3>3.0.co;2-r · Cited by 289
Self-citationEndocannabinoids and the regulation of their levels in health and disease
Di Marzo, V., & Petrosino, S. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32803dbdec · Cited by 289
Self-citationManzanares, J., Julian, M., & Carrascosa, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019527 · Cited by 287
Artmann, A., Petersen, G., Hellgren, L. I., Boberg, J., Skonberg, C., Nellemann, C., Hansen, S. H., & Hansen, H. S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.01.006 · Cited by 287
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
Wagner, J. A., Varga, K., Ellis, E. F., Rzigalinski, B. A., Martin, B. R., & Kunos, G. (1997) · Nature · doi:10.1038/37371 · Cited by 284
Di, S., Malcher-Lopes, R., Marcheselli, V. L., Bazan, N. G., & Tasker, J. G. (2005) · Endocrinology · doi:10.1210/en.2005-0610 · Cited by 282
Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cells
Sánchez, C., Galve-Roperh, I., Canova, C., Brachet, P., & Guzmán, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01085-0 · Cited by 280
Arachidonic acid as a neurotoxic and neurotrophic substance
Katsuki, H., & Okuda, S. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00016-o · Cited by 280
Evidence against the presence of an anandamide transporter
Glaser, S. T., Abumrad, N. A., Fatade, F., Kaczocha, M., Studholme, K. M., & Deutsch, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730816100 · Cited by 279
Tanda, G., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1485-z · Cited by 277
Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0375-5 · Cited by 276
Mor, M., Rivara, S., Lodola, A., Plazzi, P. V., Tarzia, G., Duranti, A., Tontini, A., Piersanti, G., Kathuria, S., & Piomelli, D. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031140x · Cited by 276
Self-citationStructural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor
Sheskin, T., Hanuš, L., Slager, J., Vogel, Z., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960752x · Cited by 275
BISOGNO, T., SEPE, N., MELCK, D., MAURELLI, S., PETROCELLIS, L. D., & MARZO, V. D. (1997) · Biochemical Journal · doi:10.1042/bj3220671 · Cited by 275
Cannabinoid receptors and endocannabinoids: Evidence for new players
Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 275
Boger, D. L., Sato, H., Lerner, A. E., Hedrick, M. P., Fecik, R. A., Miyauchi, H., Wilkie, G. D., Austin, B. J., Patricelli, M. P., & Cravatt, B. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5044 · Cited by 272
Endocannabinoid signaling in microglial cells
Stella, N. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.037 · Cited by 272
Yamashita, A., Hayashi, Y., Nemoto-Sasaki, Y., Ito, M., Oka, S., Tanikawa, T., Waku, K., & Sugiura, T. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.10.001 · Cited by 268
Structural determinants for recognition and translocation by the anandamide transporter
Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S. Y., Goutopoulos, A., Xie, X.-Q., & Makriyannis, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5802 · Cited by 268
Self-citationThe cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 267
Melck, D., De Petrocellis, L., Orlando, P., Bisogno, T., Laezza, C., Bifulco, M., & Di Marzo, V. (2000) · Endocrinology · doi:10.1210/endo.141.1.7239 · Cited by 265
Self-citationCircuitry for associative plasticity in the amygdala involves endocannabinoid signaling
Azad, S. C., Monory, K., Marsicano, G., Cravatt, B. F., Lutz, B., Zieglgänsberger, W., & Rammes, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2134-04.2004 · Cited by 263
Schmid, P. C., Paria, B. C., Krebsbach, R. J., Schmid, H. H. O., & Dey, S. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4188 · Cited by 264
Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization
Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C., & Mackie, K. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03773.1999 · Cited by 261
Ho, W., Barrett, D. A., & Randall, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.324 · Cited by 259
Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors
Wagner, J. A., Varga, K., Járai, Z., & Kunos, G. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.429 · Cited by 257
Cannabis use during pregnancy: Pharmacokinetics and effects on child development
Grant, K. S., Petroff, R., Isoherranen, N., Stella, N., & Burbacher, T. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.014 · Cited by 255
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
Croxford, J. L., & Yamamura, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.023 · Cited by 255
Hillard, C. J. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00051-4 · Cited by 254
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
Finn, D. P., Haroutounian, S., Hohmann, A. G., Krane, E., Soliman, N., & Rice, A. S. C. (2021) · Pain · doi:10.1097/j.pain.0000000000002268 · Cited by 254
Melis, M., Perra, S., Muntoni, A. L., Pillolla, G., Lutz, B., Marsicano, G., Di Marzo, V., Gessa, G. L., & Pistis, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3502-04.2004 · Cited by 253
Self-citationThe Role of the Endocannabinoid System in the Brain–Gut Axis
Sharkey, K. A., & Wiley, J. W. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.015 · Cited by 253
Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400997101 · Cited by 230
Self-citationCannabinoid and opioid interactions: implications for opiate dependence and withdrawal
Scavone, J. L., Sterling, R. C., & Van Bockstaele, E. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.034 · Cited by 209
Mitrirattanakul, S., Ramakul, N., Guerrero, A. V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K. F., & Spigelman, I. (2006) · Pain · doi:10.1016/j.pain.2006.06.016 · Cited by 207
“The endogenous cannabinoids which bind to their receptors are synthesized on demand by neuronal tissues (Di Marzo et al., 1994; Stella et al., 1997).”
BackgroundMelck, D., Bisogno, T., De Petrocellis, L., Chuang, H.-H., Julius, D., Bifulco, M., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1105 · Cited by 188
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Self-citationRusso, R., LoVerme, J., La Rana, G., Compton, T. R., Parrott, J., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Calignano, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119941 · Cited by 182
Self-citationMelck, D., Rueda, D., Galve-Roperh, I., De Petrocellis, L., Guzmán, M., & Di Marzo, V. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01639-7 · Cited by 168
Self-citationPatel, S., & Hillard, C. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06266.x · Cited by 162
The Biodisposition and Metabolism of Anandamide in Mice
Willoughby, K. A., Moore, S. F., Martin, B. R., & Ellis, E. F. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36812-0 · Cited by 159
Jin, X.-H., Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606369200 · Cited by 155
Smith, F. L., Fujimori, K., Lowe, J., & Welch, S. P. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00583-2 · Cited by 154
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706699 · Cited by 155
Lemos, J. I., Resstel, L. B., & Guimarães, F. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.045 · Cited by 146
Chiurchiù, V., van der Stelt, M., Centonze, D., & Maccarrone, M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.007 · Cited by 140
“At least five different pathways can generate AEA (Di Marzo et al., 1994; Leung et al., 2006; Liu et al., 2006), the most studied being the release of AEA from membrane precursors via Nacylphosphatidyl-ethanolamine (NAPE)-specific phospholipase D (NAPE-PLD) (Okamoto et al., 2004).”
More surprises lying ahead. The endocannabinoids keep us guessing
Piomelli, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.026 · Cited by 128
Self-citationNyilas, R., Dudok, B., Urbán, G. M., Mackie, K., Watanabe, M., Cravatt, B. F., Freund, T. F., & Katona, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5102-07.2008 · Cited by 119
Anandamide Inhibits Nuclear Factor-κB Activation through a Cannabinoid Receptor-Independent Pathway
Sancho, R., Calzado, M. A., Di Marzo, V., Appendino, G., & Muñoz, E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.429 · Cited by 120
Vela, G., Ruiz-gayo, M., & Fuentes, J. A. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00032-2 · Cited by 118
Cristino, L., Starowicz, K., De Petrocellis, L., Morishita, J., Ueda, N., Guglielmotti, V., & Di Marzo, V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.047 · Cited by 115
Enzymological studies on the biosynthesis of N-acylethanolamines
Ueda, N., Tsuboi, K., & Uyama, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.010 · Cited by 112
Ruggiero, R. N., Rossignoli, M. T., Marques, D. B., de Sousa, B. M., Romcy-Pereira, R. N., Lopes-Aguiar, C., & Leite, J. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.732360 · Cited by 111
Cannabinoids modulate pain by multiple mechanisms of action
Richardson, J. D. (2000) · The Journal of Pain · doi:10.1016/s1526-5900(00)90082-8 · Cited by 109
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106
Large Receptor Reserve for Cannabinoid Actions in the Central Nervous System
Gifford, A. N., Bruneus, M., Gatley, S. J., Lan, R., Makriyannis, A., & Volkow, N. D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37979-0 · Cited by 100
Fatty Acid Amide Hydrolase: A Gate-Keeper of the Endocannabinoid System
Fezza, F., De Simone, C., Amadio, D., & Maccarrone, M. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_4 · Cited by 99
Endocannabinoids and pregnancy.
Taylor, A. H., Amoako, A. A., Bambang, K., Karasu, T., Gebeh, A., Lam, P. M. W., Marzcylo, T. H., & Konje, J. C. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.012 · Cited by 89
Melis, M., Carta, S., Fattore, L., Tolu, S., Yasar, S., Goldberg, S. R., Fratta, W., Maskos, U., & Pistis, M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.016 · Cited by 89
Reche, I., Fuentes, J. A., & Ruiz-Gayo, M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00752-2 · Cited by 87
Chapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs
Gaetani, S., Dipasquale, P., Romano, A., Righetti, L., Cassano, T., Piomelli, D., & Cuomo, V. (2009) · International Review of Neurobiology · doi:10.1016/s0074-7742(09)85005-8 · Cited by 83
Self-citationDa Fonseca Pacheco, D., Klein, A., De Castro Perez, A., Da Fonseca Pacheco, C. M., De Francischi, J. N., & Duarte, I. D. G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.175 · Cited by 81
Boileau, I., Mansouri, E., Williams, B., Le Foll, B., Rusjan, P., Mizrahi, R., Tyndale, R. F., Huestis, M. A., Payer, D. E., Wilson, A. A., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.012 · Cited by 82
Nadal, X., La Porta, C., Andreea Bura, S., & Maldonado, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.077 · Cited by 76
Synaptic activation of kainate receptors gates presynaptic CB1 signaling at GABAergic synapses
Lourenço, J., Cannich, A., Carta, M., Coussen, F., Mulle, C., & Marsicano, G. (2010) · Nature Neuroscience · doi:10.1038/nn.2481 · Cited by 69
Jansma, J. M., van Hell, H. H., Vanderschuren, L. J. M. J., Bossong, M. G., Jager, G., Kahn, R. S., & Ramsey, N. F. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.6 · Cited by 58
Pharmacological activation of kainate receptors drives endocannabinoid mobilization
Lourenço, J., Matias, I., Marsicano, G., & Mulle, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3512-10.2011 · Cited by 46
La Rana, G., Russo, R., D'Agostino, G., Sasso, O., Raso, G. M., Iacono, A., Meli, R., Piomelli, D., & Calignano, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.021 · Cited by 42
“The endogenous acylethanolamides are a group of substances generated on demand through stimulus-dependent cleavage of membrane phospholipid precursors and, after their release, undergo a rapid inactivation (Di Marzo et al., 1994; Piomelli et al., 1998).”
BackgroundRodella, L. F., Borsani, E., Rezzani, R., Ricci, F., Buffoli, B., & Bianchi, R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.031 · Cited by 32
URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats
Hasanein, P., Parviz, M., Keshavarz, M., & Roohbakhsh, A. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-026 · Cited by 14
Cannabinoid receptor systems: therapeutic targets for tumour intervention.
Jones, S., & Howl, J. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.6.749 · Cited by 13
“AEA biosynthesis requires the phospholipase D-mediated hydrolysis of the phospholipid precursor N-arachidonylphosphatidylethanolamine [40,41].”
BackgroundChapter 4.5 The endocannabinoid system and anxiety responses
Bortolato, M., & Piomelli, D. (2008) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(07)00014-8 · Cited by 7
Self-citation
Metadata
- Authors
- Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D.
- Venue
- Nature
- Published
- 1994-12
- Volume
- 372
- Issue
- 6507
- Pages
- 686-691
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083371696
- Cited by
- 1,587
- References
- 19
- FWCI
- 32.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.